VistaGen Therapeutics, Inc | TalkMarkets

People who follow this stock (35)

View All

Latest Posts

About This Stock More About This Stock

Week In Review: BioKangtai Acquires China Rights To AstraZeneca's COVID-19 Vaccine

Article By: ChinaBio® Today

Saturday, August 8, 2020 12:13 PM EDT

BioKangtai, a Guangdong vaccine company, in-licensed rights to develop, manufacture, and market AstraZeneca's COVID-19 vaccine in China. Biogen announced a $2 billion deal to partner Denali Therapeutics' potential Parkinson's Disease therapy.

In this article: AZN, BIIB, VTGN, GTHX, ZLAB, DNLI, DCPH

Read

Premarket Biotech Digest – DMPI Receives Approval, PFE Slapped From FDA

Article By: KKD Healthcare Analytics

Friday, June 23, 2017 9:31 AM EDT

DelMar Pharmaceuticals announced that it has received Institutional Review Board approval to conduct a Phase 3 clinical trial. Pfizer received a setback from the FDA. Roche announced receiving the FDA approval .

In this article: PFE, RHHBY, TROV, QGEN, DMPI, IONS, VTGN, PRTO

Read

All Posts

$VTGN

Comments Status Updates

Rotation Opportunity As Three Top Psychedelic Stocks Explode

Corey Gaber • 12/15/2020 3:37:26 AM

Great article @TalkMarkets $MMEDF has been a BANGER $VTGN

is Kim Jong gonna make everyone take PH10??!!!!

VistaGen Therapeutics: Interesting Prospects

Alexis Renault • 10/5/2017 7:43:59 PM

Thanks Terry! Will take a closer look at $VTGN.

VistaGen Therapeutics: Interesting Prospects

Derek Snyder • 10/4/2017 9:07:54 AM

Your argument for acquisition sounds convincing, but I wonder if there have been any such overtures. Know if that's the case? Which companies would be the most likely to target #Vistagen? $VTGN.